These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37001327)

  • 1. Effect of LGR4/EGFR signaling on cell growth and cancer stem cell-like characteristics in liver cancer.
    Liu Y; Zhang Y; Chen S; Zhong X; Liu Q
    Cytokine; 2023 May; 165():156185. PubMed ID: 37001327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rspo2-LGR4 exacerbates hepatocellular carcinoma progression via activation of Wnt/β-catenin signaling pathway.
    Bi Y; Zhang L; Song Y; Sun L; Mulholland MW; Yin Y; Zhang W
    Gastroenterol Hepatol; 2024 Apr; 47(4):352-365. PubMed ID: 37437654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. R-spondin 2-LGR4 system regulates growth, migration and invasion, epithelial-mesenchymal transition and stem-like properties of tongue squamous cell carcinoma via Wnt/β-catenin signaling.
    Zhang L; Song Y; Ling Z; Li Y; Ren X; Yang J; Wang Z; Xia J; Zhang W; Cheng B
    EBioMedicine; 2019 Jun; 44():275-288. PubMed ID: 31097406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hsa_circ_0003945 promotes progression of hepatocellular carcinoma by mediating miR-34c-5p/LGR4/β-catenin axis activity.
    Lyu LH; Zhang CY; Yang WJ; Jin AL; Zhu J; Wang H; Liu T; Wang BL; Cheng JW; Yang XR; Guo W
    J Cell Mol Med; 2022 Apr; 26(8):2218-2229. PubMed ID: 35170199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LGR4 modulates breast cancer initiation, metastasis, and cancer stem cells.
    Yue Z; Yuan Z; Zeng L; Wang Y; Lai L; Li J; Sun P; Xue X; Qi J; Yang Z; Zheng Y; Fang Y; Li D; Siwko S; Li Y; Luo J; Liu M
    FASEB J; 2018 May; 32(5):2422-2437. PubMed ID: 29269400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Wnt-Independent LGR4-EGFR Signaling Axis in Cancer Metastasis.
    Yue F; Jiang W; Ku AT; Young AIJ; Zhang W; Souto EP; Gao Y; Yu Z; Wang Y; Creighton CJ; Nagi C; Wang T; Hilsenbeck SG; Feng XH; Huang S; Coarfa C; Zhang XH; Liu Q; Lin X; Li Y
    Cancer Res; 2021 Sep; 81(17):4441-4454. PubMed ID: 34099494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Function for KLF4 in Modulating the De-differentiation of EpCAM
    Karagonlar ZF; Akbari S; Karabicici M; Sahin E; Avci ST; Ersoy N; Ates KE; Balli T; Karacicek B; Kaplan KN; Celiker C; Atabey N; Erdal E
    Cells; 2020 May; 9(5):. PubMed ID: 32408542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD133 confers cancer stem-like cell properties by stabilizing EGFR-AKT signaling in hepatocellular carcinoma.
    Jang JW; Song Y; Kim SH; Kim JS; Kim KM; Choi EK; Kim J; Seo HR
    Cancer Lett; 2017 Mar; 389():1-10. PubMed ID: 28034805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.
    Toh TB; Lim JJ; Hooi L; Rashid MBMA; Chow EK
    J Hepatol; 2020 Jan; 72(1):104-118. PubMed ID: 31541681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ELK3 promotes the migration and invasion of liver cancer stem cells by targeting HIF-1α.
    Lee JH; Hur W; Hong SW; Kim JH; Kim SM; Lee EB; Yoon SK
    Oncol Rep; 2017 Feb; 37(2):813-822. PubMed ID: 27959451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of LGR4 inhibits proliferation and odonto/osteogenic differentiation of stem cells from apical papillae.
    Zhou M; Guo S; Yuan L; Zhang Y; Zhang M; Chen H; Lu M; Yang J; Ma J
    J Mol Histol; 2017 Dec; 48(5-6):389-401. PubMed ID: 28986711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LGR4 cooperates with PrPc to endow the stemness of colorectal cancer stem cells contributing to tumorigenesis and liver metastasis.
    Cheng Q; Zheng H; Li M; Wang H; Guo X; Zheng Z; Chen C; Liu J; Zhan T; Li Z; Wu H; Han J; Liu L; Tang T; Chen Q; Du L
    Cancer Lett; 2022 Aug; 540():215725. PubMed ID: 35561877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer stem-like cell properties are regulated by EGFR/AKT/β-catenin signaling and preferentially inhibited by gefitinib in nasopharyngeal carcinoma.
    Ma L; Zhang G; Miao XB; Deng XB; Wu Y; Liu Y; Jin ZR; Li XQ; Liu QZ; Sun DX; Testa JR; Yao KT; Xiao GH
    FEBS J; 2013 May; 280(9):2027-41. PubMed ID: 23461856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of LGR4 (GPR48) in Normal and Cancer Processes.
    Ordaz-Ramos A; Rosales-Gallegos VH; Melendez-Zajgla J; Maldonado V; Vazquez-Santillan K
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of amphiregulin gene expression by β-catenin signaling in human hepatocellular carcinoma cells: a novel crosstalk between FGF19 and the EGFR system.
    Latasa MU; Salis F; Urtasun R; Garcia-Irigoyen O; Elizalde M; Uriarte I; Santamaria M; Feo F; Pascale RM; Prieto J; Berasain C; Avila MA
    PLoS One; 2012; 7(12):e52711. PubMed ID: 23285165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LGR4 maintains HGSOC cell epithelial phenotype and stem-like traits.
    Wang Z; Yin P; Sun Y; Na L; Gao J; Wang W; Zhao C
    Gynecol Oncol; 2020 Dec; 159(3):839-849. PubMed ID: 32980127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lgr4 promotes glioma cell proliferation through activation of Wnt signaling.
    Yu CY; Liang GB; Du P; Liu YH
    Asian Pac J Cancer Prev; 2013; 14(8):4907-11. PubMed ID: 24083766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of Cancer Stemness by Novel Diterpenoid Ovatodiolide Inhibits Hepatic Cancer Stem Cell-Like Traits by Repressing Wnt/[Formula: see text]-Catenin Signaling.
    Liu M; Bamodu OA; Kuo KT; Lee WH; Lin YK; Wu ATH; M H; Tzeng YM; Yeh CT; Tsai JT
    Am J Chin Med; 2018; 46(4):891-910. PubMed ID: 29792038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-206 inhibits liver cancer stem cell expansion by regulating EGFR expression.
    Liu C; Li J; Wang W; Zhong X; Xu F; Lu J
    Cell Cycle; 2020 May; 19(10):1077-1088. PubMed ID: 32286127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA‑137 regulates hypoxia‑mediated migration and epithelial‑mesenchymal transition in prostate cancer by targeting LGR4 via the EGFR/ERK signaling pathway.
    Zhang H; Liang F; Yue J; Liu P; Wang J; Wang Z; Li H; Cheng D; Du J; Zhang K; Du P
    Int J Oncol; 2020 Aug; 57(2):540-549. PubMed ID: 32626928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.